Ketamine for Complex Regional Pain Syndrome

 

Ketamine for Complex Regional Pain Syndrome Summary

Research into Ketamine for pain management shows it to be a safe alternative to opioids in emergency settings. A 2025 study has shown that 20-46% of patients achieved clinically meaningful improvements in pain management and found the benefits were sustained 6 months post treatment. A 2025 study found Ketamine to match the effect of opioids for immediate pain relief without the side effects. Overall the studies show that Ketamine is an effective tool for treating pain.

Complex Regional Pain Syndrome(CRPS) causes persistent, debilitating nerve pain. It is usually caused by an injury and most often affects one limb. The cause of Complex Regional Pain Syndrome is believed to be malfunction or damage from trauma to the central and peripheral nervous system. Symptoms can range from excessive pain to swelling and even changes to body temperature and skin color. Unfortunately there is no cure for Complex Regional Pain Syndrome, and the only way forward is to manage the pain through therapy. One way to manage CRPS is through Ketamine therapy, which has been found to reduce pain for several weeks.

Note: Ketamine is FDA approved for general use in anesthesia and as of August 2025 it is approved for surgical pain management in perioperative settings.

1) Mechanism of Action

Ketamine is used as an analgesic, especially for severe acute pain and selected chronic pain syndromes.

  • NMDA receptor antagonism causes a reduction in glutamate-mediated pain transmission
  • Decreases central sensitization (core feature of Complex Regional Pain Syndrome)
  • Reverses opioid tolerances
  • Inhibits the wind-up phenomenon (progressive amplification of pain signals)
  • Enhances descending inhibitory pain pathways

These effects are especially relevant in CRPS.

2) Clinical Indications

  • Refractory Complex Regional Pain Syndrome (Type I or Type II)
  • Severe neuropathic pain with allodynia and hyperalgesia
  • Opioid-tolerant or opioid-resistant pain

Ketamine is often used as an adjunct rather than a first-line analgesic.

3) Clinical Effects

  • Improved pain control in opioid-resistant cases
  • Reduction in pain intensity
  • Reduction in hyperalgesia and allodynia
  • Improved function and mobility

In chronic pain, ketamine may sometimes provide relief that lasts beyond the infusion period by helping reset abnormal pain processing and can last for days and even weeks after the ketamine session. Repeated infusions can prolong the benefit.

4) Potential Advantages

  • Targets central sensitization
  • Opioid-sparing, which may reduce opioid adverse effects and opioid dose requirements
  • Minimal respiratory depression
  • Useful in some hemodynamically unstable patients
  • May produce longer lasting relief

These features make ketamine valuable in emergency, perioperative, and selected chronic pain settings.

5) Limitations and Risks

  • Variable response in chronic pain patients
  • Short duration of benefit in some cases
  • Need for monitoring at higher doses
  • Potential for misuse or dependence

6) Adverse Effects

  • Dissociation
  • Hallucinations or perceptual disturbances
  • Dizziness
  • Nausea/vomiting
  • Sedation
  • Increased blood pressure and heart rate

With repeated or long-term use

  • Cystitis (ketamine bladder syndrome)
  • Cognitive effects
  • Potential hepatotoxicity

7) Current Clinical Role

  • Used in Complex Regional Pain Syndrome treatment programs
  • Reserved for severe treatment resistant chronic pain
  • Typically used as an adjunct to other analgesics